Do Artemisia annua L. compounds have SARS-CoV-2 antiviral potential?
€ 18.00 · 5 (202) · In Magazzino
Di uno scrittore di uomini misteriosi
Frontiers The COVID-19 Treatment Landscape: A South African Perspective on a Race Against Time
Artemisia annua L. extracts inhibit the in vitro replication of SARS-CoV-2 and two of its variants - ScienceDirect
Artemisia Spp. Derivatives for COVID-19 Treatment: Anecdotal Use, Political Hype, Treatment Potential, Challenges, and Road Map to Randomized Clinical Trials in: The American Journal of Tropical Medicine and Hygiene Volume 103 Issue 3 (2020)
Artemisia plant extract prevents SARS-CoV-2 replication in vitro
Antiviral, virucidal and antioxidant properties of Artemisia annua against SARS-CoV-2 - ScienceDirect
Frontiers A Computational Approach to Elucidate the Interactions of Chemicals From Artemisia annua Targeted Toward SARS-CoV-2 Main Protease Inhibition for COVID-19 Treatment
Synthesis and in vitro Study of Artemisinin/Synthetic Peroxide‐Based Hybrid Compounds against SARS‐CoV‐2 and Cancer - Herrmann - 2022 - ChemMedChem - Wiley Online Library
The Role of Inflammasomes in COVID-19: Potential Therapeutic Targets
Therapeutic Options for the SARS-CoV-2 Virus: Is There a Key in Herbal Medicine? - Nitin Sharma, Giriraj T. Kulkarni, Anant Narayan Bhatt, Saurabh Satija, Lubhan Singh, Anjana Sharma, Kamal Dua, Ritu Karwasra